Welcome to our dedicated page for DSACW news (Ticker: DSACW), a resource for investors and traders seeking the latest updates and insights on DSACW stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DSACW's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DSACW's position in the market.
Daedalus Special Acquisition Corp (NYSE: DSAC) closed an upsized initial public offering on Dec 10, 2025, raising $250,000,000 from the sale of 25,000,000 units at $10.00 per unit, including 2,500,000 units from the underwriters' partial over-allotment.
Each unit comprises one Class A ordinary share and one-fourth of one redeemable warrant; whole warrants exercise at $11.50. Units began trading on the Nasdaq Global Market as DSACU on Dec 9, 2025; ordinary shares and warrants are expected to trade as DSAC and DSACW once separated. BTIG acted as sole book-running manager and the SEC declared the registration statement effective on Dec 8, 2025.
Daedalus Special Acquisition Corp (NASDAQ:DSAC) announced an upsized initial public offering of 22,500,000 units at $10.00 per unit, representing gross proceeds of $225,000,000. Each unit includes one Class A ordinary share and one-fourth of one redeemable warrant, with each whole warrant exercisable at $11.50 per share.
Units are expected to begin trading on the Nasdaq Global Market under DSACU on December 9, 2025; ordinary shares and warrants are expected to trade as DSAC and DSACW after separation. BTIG is sole book-running manager and holds a 45-day option to purchase up to 3,375,000 additional units to cover over-allotments. The SEC declared the registration statement effective on December 8, 2025, and the offering is expected to close on December 10, 2025, subject to customary conditions.
